Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
March 24, 2018
Loss of IDH2 Accelerates Age-related Hearing Loss in Male Mice
Karessa White, Mi-Jung Kim, Chul Han, et al.
Blood
|
December 23, 2022
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial
Aikaterini Panopoulou, David A Cairns, Amy Holroyd, et al.
Plos One
|
August 29, 2020
Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis
Sera Thomas, June C Carroll, M Catherine Brown, et al.
British Journal of Sports Medicine
|
October 19, 2014
Competing with injuries: injuries prior to and during the 15th FINA World Championships 2013 (aquatics)
Margo Mountjoy, Astrid Junge, Sarah Benjamen, et al.
Leukemia & Lymphoma
|
December 28, 2020
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience
Nadjoua Maouche, Bhuvan Kishore, Matthew W Jenner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 1, 2014
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Abul Kalam Azad, Xin Qiu, Kevin Boyd, et al.
Blood Cancer Journal
|
July 17, 2025
Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
Christina Messiou, Nuria Porta, Dow-Mu Koh, et al.
Radiology. Imaging Cancer
|
September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma
Christina Messiou, Nuria Porta, Bhupinder Sharma, et al.
Experimental Gerontology
|
July 26, 2019
Increased burden of mitochondrial DNA deletions and point mutations in early-onset age-related hearing loss in mitochondrial mutator mice
Mi-Jung Kim, Suraiya Haroon, Guang-Di Chen, et al.
The Lancet. Haematology
|
September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Gordon Cook, A John Ashcroft, Ethan Senior, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
March 24, 2018
Loss of IDH2 Accelerates Age-related Hearing Loss in Male Mice
Karessa White, Mi-Jung Kim, Chul Han, et al.
Blood
|
December 23, 2022
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial
Aikaterini Panopoulou, David A Cairns, Amy Holroyd, et al.
Plos One
|
August 29, 2020
Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis
Sera Thomas, June C Carroll, M Catherine Brown, et al.
British Journal of Sports Medicine
|
October 19, 2014
Competing with injuries: injuries prior to and during the 15th FINA World Championships 2013 (aquatics)
Margo Mountjoy, Astrid Junge, Sarah Benjamen, et al.
Leukemia & Lymphoma
|
December 28, 2020
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience
Nadjoua Maouche, Bhuvan Kishore, Matthew W Jenner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 1, 2014
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Abul Kalam Azad, Xin Qiu, Kevin Boyd, et al.
Blood Cancer Journal
|
July 17, 2025
Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
Christina Messiou, Nuria Porta, Dow-Mu Koh, et al.
Radiology. Imaging Cancer
|
September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma
Christina Messiou, Nuria Porta, Bhupinder Sharma, et al.
Experimental Gerontology
|
July 26, 2019
Increased burden of mitochondrial DNA deletions and point mutations in early-onset age-related hearing loss in mitochondrial mutator mice
Mi-Jung Kim, Suraiya Haroon, Guang-Di Chen, et al.
The Lancet. Haematology
|
September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Gordon Cook, A John Ashcroft, Ethan Senior, et al.
Page
of 5